Skip to main content
SpringerLink
Log in

Priming of human neutrophil functions by tumor necrosis factor: Enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and f-Met-Leu-Phe

  • Original Articles
  • Published:
Inflammation Aims and scope Submit manuscript

Abstract

Recombinant human tumor necrosis factor-α (rTNF) stimulated increased generation of Superoxide anion (O −2 ) by human neutrophils in a concentration-dependent fashion. Preincubation of human neutrophils with rTNF (2.2–2200 units/ml) for 10 min enhanced the subsequent generation of O −2 in response to C5a and f-MetLeu-Phe(FMLP). Recombinant TNF did not enhance O −2 generation by neutrophils stimulated with phorbol myristate acetate (PMA). Recombinant TNF alone failed to induce release of myeloperoxidase (MPO) and lysozyme by neutrophils. However, it did enhance the release of MPO and lysozyme by neutrophils stimulated with C5a and FMLP, but not with PMA. Although rTNF alone (0.001–50,000 units/ml) was not chemotactic for neutrophils, preincubation of neutrophils with rTNF (0.001–0.1 units/ml) enhanced the chemotactic activity of suboptimal concentrations of C5a (0.1 nM) and FMLP (5 nM). Neutrophils treated with high concentrations of rTNF (100–10,000 units/ml) showed inhibition of random movement and of chemotaxis induced by C5a or FMLP. We conclude from these studies that rTNF primes neutrophils for enhanced responses to subsequent stimuli and thus may augment the inflammatory response by increased oxidant production and lysosomal enzyme release and promote down-regulation of chemotactic movement.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Beutler, B., andA. Cerami. 1986. Cachectin and tumor necrosis factor as two sides of the same biological coin.Nature 320:584–588.

    Google Scholar 

  2. Urban, J. L., H. M. Shepard, J. L. Rothstein, B. J. Sugarman, andH. Schreiber. 1986. Tumor necrosis factor: A potent effector molecule for tumor cell killing by activated macrophages.Proc. Natl. Acad. Sci. U.S.A. 83:5233–5237.

    Google Scholar 

  3. Dinarello, C. A., J. G. Cannon, S. M. Wolff, H. A. Bernheim, B. Beutler, A. Cerami, I. S. Figari, M. A. Palladino, andJ. V. O'Connor. 1986. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.J. Exp. Med. 163:1433–1450.

    Google Scholar 

  4. Tracey, K. J., B. Beutler, S. F. Lowry, J. Merryweather, S. Wolpe, I. W. Milsark, J. Hariri, T. J. Fahey, III,A. Zentella, J. D. Albert, G. T. Shires, andA. Cerami. 1986. Shock and tissue injury induced by recombinant human cachectin.Science 234:470–474.

    Google Scholar 

  5. Yuo, A., S. Kitagawa, I. Suzuki, A. Urabe, T. Okabe, M. Saito, andF. Takaku. 1989. Tumor necrosis factor as an activator of human granulocytes. Potentiation of the metabolisms triggered by the Ca2+ mobilizing agonists.J. Immunol. 142:1678–1684.

    Google Scholar 

  6. Crouch, S., andJ. Fletcher. 1991. The priming effects of the products of stimulated mononuclear cells on the response of neutrophils to C5a des arg.Br. J. Hematol. 77:158–164.

    Google Scholar 

  7. Berkow, R. L., D. Wang, J. W. Larrick, R. W. Dodson, andT. H. Howard. 1987. Enhancement of neutrophil Superoxide production by preincubation with recombinant human tumor necrosis factor.J. Immunol. 139:3783–3791.

    Google Scholar 

  8. Ferrante, A., M. Nandoskar, A. Walz, D. H. B. Goh, andI. C. Kowanko. 1988. Effects of tumor necrosis factor alpha and interleukin-1 alpha and beta on human neutrophil migration, respiratory burst and degranulation.Int. Arch. Allergy Appl. Immunol. 86:82–91.

    Google Scholar 

  9. Klebanoff, S. J., M. A. Vadas, J. M. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, andA. M. Waltersdorph. 1986. Stimulation of neutrophils by tumor necrosis factor.J. Immunol. 136:4220–4225.

    Google Scholar 

  10. Richter, J., T. Andersson, andI. Olsson. 1989. Effect of tumor necrosis factor and granulocyte/macrophage colony-stimulating factor on neutrophil degranulation.J. Immunol. 142:3199–3205.

    Google Scholar 

  11. Figari, I. S., N. A. Mori, andM. A. Palladino, Jr. 1987. Regulation of neutrophil migration and Superoxide production by recombinant tumor necrosis factors-α and -β: Comparison to recombinant interferon-α and interleukin-1α.Blood 70:979–984.

    Google Scholar 

  12. Ming, W. J., L. Bersam, andA. Mantovani. 1987. Tumor necrosis factor is chemotactic for monocytes and polymorphonuclear leukocytes.J. Immunol. 138:1469–1474.

    Google Scholar 

  13. Ozaki, Y., T. Ohashi, Y. Niwa, andS. Kume. 1988. Effects of recombinant DNA-produced tumor necrosis factor on various parameters of neutrophil function.Inflammation 12:297–309.

    Google Scholar 

  14. Kharazmi, A., H. Nielsen, andK. Bendtzen. 1988. Modulation of human neutrophil and monocyte chemotaxis and Superoxide responses by recombinant TNF-alpha and GM-CSF.Immunobiology 177:363–370.

    Google Scholar 

  15. Newman, I., andP. C. Wilkinson. 1989. Chemotactic activity of lymphotoxin and tumor necrosis factor alpha for human neutrophils.Immunology 66:318–320.

    Google Scholar 

  16. Kownatzki, E., A. Kapp, andS. Uhrich. 1988. Modulation of human neutrophilic granulocyte functions by recombinant human tumor necrosis factor and recombinant human Iymphotoxin.Clin. Exp. Immunol. 74:143–148.

    Google Scholar 

  17. Mrowietz, V., J. M. Schroder, andE. Christophers. 1988. Recombinant human tumor necrosis factor alpha lacks chemotactic activity for human peripheral blood neutrophils and monocytes.Biochem. Biophys. Res. Commun. 153:1223–1228.

    Google Scholar 

  18. Schell-Frederick, E., T. Tepass, G. Lorscheidt, M. Pfeundschuh, M. Schcaadt, andV. Diehl. 1989. Effects of recombinant tumor necrosis factor (rHuTNFα) on human neutrophils and monocytes: In vitro, ex vivo and in vivo.Eur. J. Hematol. 43:286–296.

    Google Scholar 

  19. Yonemaru, M., K. E. Stephens, A. Ishizaka, H. Zheng, R. S. Hogue, J. J. Crowley, J. R. Hatherill, andT. A. Raffin. 1989. Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity.J. Lab. Clin. Med. 114:674–681.

    Google Scholar 

  20. Atkinson, Y. H., W. A. Marasco, A. F. Lopez, andM. A. Vadas. 1988. Recombinant human tumor necrosis factor α. Regulation ofN-formylmethionylleucylphenylalanine receptor affinity and function on human neutrophils.J. Clin. Invest. 81:759–765.

    Google Scholar 

  21. Salyer, J., J. Bohnsack, W. Knape, A. Shigeoka, E. Ashwood, andH. Hill. 1990. Mechanism of tumor necrosis factor-α alteration of PMN adhesion and migration.Am. J. Pathol. 136:831–841.

    Google Scholar 

  22. Shalaby, M. R., M. A. Palladino, Jr., S. E. Hirabayashi, T. E., Essalu, G. D. Lewis, H. M. Shepard, andB. B. Aggarwal. 1987. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha.J. Leukocyte Biol. 41:196–204.

    Google Scholar 

  23. Meyer, J. D., R. W. Yurt, R. Duhaney, D. G. Hesse, K. J. Tracey, Y. Fong, M. Verma, T. Shires, P. Dineen, S. F. Lowry, andJ. M. Davis. 1988. Tumor necrosis factor-enhanced leukotriene B4 generation and chemotaxis in human neutrophils.Arch. Surg. 123:1454–1458.

    Google Scholar 

  24. Bajaj, M. S., R. R. Kew, R. O. Webster, andT. M. Hyers. 1989. Enhancement of human neutrophil function by recombinant tumor necrosis factor.Am. Rev. Respir. Dis. 139:A355.

    Google Scholar 

  25. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human peripheral blood.Scand. J. Clin. Lab. Invest. 21(Suppl 97):77–89.

    Google Scholar 

  26. Johnston, R. B., B. B. Keele, H. P. Misra, J. E. Lehmeyer, L. S. Webb, R. L. Baehner, andK. V. Rajagopalan. 1975. The role of Superoxide anion generation in phagocytic bacterial activity.J. Clin. Invest. 55:1357–1372.

    Google Scholar 

  27. Creasey, A. A., L. V. Doyle, M. T. Reynolds, T. Jung, L. S. Ling, andR. Vitt. 1987. Biological effects of recombinant human tumor necrosis factor and its novel mutants on tumor and normal cell lines.Cancer Res. 47:145–149.

    Google Scholar 

  28. Wang, A., A. A. Creasey, M. B. Ladner, L. S. Lin, J. Strickler, J. Van Arsdell, J. N. Yamamoto, andD. F. Mark. 1985. Molecular cloning of the complementary DNA for human tumor necrosis factor.Science 228:149–154.

    Google Scholar 

  29. Kew, R. R., andR. O. Webster. 1988. Gc-Globulin (vitamin D-binding protein) enhances the neutrophil chemotactic activity of C5a and C5a des Arg.J. Clin. Invest. 82:364–369.

    Google Scholar 

  30. Henson, P. M. 1971. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles.J. Immunol. 107:1535–1546.

    Google Scholar 

  31. Henson, P. M., B. Zanolari, N. A. Schwartzmann, andS. R. Hong. 1978. Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B.J. Immunol. 121:851–855.

    Google Scholar 

  32. Zigmond, S. H., andJ. G. Hirsch. 1973. Leukocyte locomotion and chemotaxis: New methods for evaluation and demonstration of a cell-derived chemotactic factor.J. Exp. Med. 137:387–410.

    Google Scholar 

  33. Maloff, B., J. Shaw, andD. Fox. 1988. A chemotaxis assay using human polymorphonuclear leukocytes stimulated by IL-1.J. Immunol. Methods 112:145–146.

    Google Scholar 

  34. Tennenberg, S., andJ. Solomkin. 1990. Activation of neutrophils by cachectin/tumor necrosis factor: Priming ofN-formyl-methionyl-leucyl-phenylalanine-induced oxidative responsiveness via receptor mobilization without degranulation.J. Leukocyte Biol. 47:217–223.

    Google Scholar 

  35. Becker, E. L. 1979. A multifunctional receptor on the neutrophil for synthetic chemotactic oligopeptides.J. Reticuloendothel. Soc. 26:701–709.

    Google Scholar 

  36. Kreutzer, D. L., J. T. O'Flaherty, W. Orr, H. J. Showell, P. A. Ward, andE. L. Becker. 1978. Quantitative comparisons of various biological responses of neutrophils to different active and inactive chemotactic factors.Immunopharmacology 1:39–47.

    Google Scholar 

  37. Berger, M., E. M. Wetzler, andR. S. Wallis. 1988. Tumor necrosis factor is the major monocyte product that increases complement receptor expression on mature human neutrophils.Blood 71:151–158.

    Google Scholar 

Download references

Author information

Author notes

  1. Richard R. Kew

    Present address: Department of Pathology, SUNY, Stony Brook, 11794, New York

Authors and Affiliations

  1. Departments of Internal Medicine and Microbiology, St. Louis University School of Medicine, St. Louis, 63110, Missouri

    Madhu S. Bajaj, Richard R. Kew, Robert O. Webster & Thomas M. Hyers

Authors
  1. Madhu S. Bajaj
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Richard R. Kew
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robert O. Webster
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Thomas M. Hyers
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bajaj, M.S., Kew, R.R., Webster, R.O. et al. Priming of human neutrophil functions by tumor necrosis factor: Enhancement of superoxide anion generation, degranulation, and chemotaxis to chemoattractants C5a and f-Met-Leu-Phe. Inflammation 16, 241–250 (1992). https://doi.org/10.1007/BF00918813

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00918813

Keywords

Search

Navigation